
	Years Ended December 31,
	2025		2024		2023
Numerator:
Net income (loss) attributable to FTS	$	133,858	$	17,214	$	(47,935)
Less: Undistributed earnings attributable to convertible preferred stockholders	(71,832)		(17,214)		—
Net income (loss) attributable to common stockholders, basic and diluted	$	62,026	$	—	$	(47,935)

Denominator:
Basic weighted average common shares attributable to FTS	114,435,259		65,020,119		51,305,065
Add: effect of dilutive securities related to share-based payment awards (A)	27,366,743		7,617,338		—
Diluted weighted average common shares attributable to FTS	141,802,002		72,637,457		51,305,065

Net income (loss) per common share attributable to FTS, basic	$0.54		$0.00		$(0.93)
Net income (loss) per common share attributable to FTS, diluted	$0.44		$0.00		$(0.93)

(A) The dilutive impact of share-based payment awards and warrants for the years ended December 31, 2025, 2024, and 2023 comprised of 22,621,883, 7,132,282, and zero shares related to stock options, 959,984, 485,056, and zero shares related to warrants, and 3,784,876, zero, and zero shares related to unvested RSUs, respectively. For the year ended December 31, 2024, 598,104 shares related to unvested RSUs were excluded from the dilutive impact as the issuance of those shares was contingent upon the satisfaction of a liquidity condition which was not satisfied as of the end of that period. As the fiscal year ended December 31, 2023 was in a net loss position, 3,609,301 potentially dilutive shares from share-based payment awards were considered, but would have been anti-dilutive and have been excluded from the computation of diluted earnings per share for that period.